Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 28542604.
- Also identified by DOI 10.1371/journal.pone.0178338 and PMC identifier 5436866.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0173299.].